ImmunSYS Announces it Hosted a Virtual Analyst Day Event on July 7, 2020 FORT LAUDERDALE, Florida, July 13, 2020 — ImmunSYS, Inc., a clinical-stage biopharmaceutical company focused on the development…
Category: Press Release
50% Complete Response Rate Observed in YourVaccx Study for Patients with Metastatic Prostate Cancer was Presented at the AACR Virtual Annual Meeting II
50% Complete Response Rate Observed in YourVaccx™ Study for Patients with Metastatic Prostate Cancer was Presented at the AACR Virtual Annual Meeting II …
ImmunSYS Welcomes George C. Prendergast, PhD, a Renowned Cancer Immunology Expert, to its Scientific Advisory Board
ImmunSYS Welcomes George C. Prendergast, PhD, a Renowned Cancer Immunology Expert, to its Scientific Advisory Board FORT LAUDERDALE, Florida, June 11, 2020 — ImmunSYS, Inc., a clinical-stage biopharmaceutical company focused…
ImmunSYS Announces Upcoming Presentation at AACR Virtual Annual Meeting II
ImmunSYS Announces Upcoming Presentation at AACR Virtual Annual Meeting II FORT LAUDERDALE, Florida, May 15, 2020 — (BUSINESS WIRE) — ImmunSYS, Inc., a clinical- stage biopharmaceutical company focused on the…
ImmunSYS Receives Top Award at BioPitch 2019
ImmunSYS Receives Top Award at BioPitch 2019 FORT LAUDERDALE (BUSINESS WIRE) – ImmunSYS, Inc., a clinical stage biotechnology company focused on the development of YourVaccxTM, a new intratumoral immunotherapy system…